Posts

Showing posts with the label 2017

Chlamydia Infections Global Clinical Trials Review, H1, 2017

Chlamydia Infections Global Clinical Trials Review, H1, 2017 Summary Radiant Insigths, Inc. clinical trial report, " Chlamydia Infections Global Clinical Trials Review, H1, 2017 " provides an overview of Chlamydia Infections clinical trials scenario. This report provides top line data relating to the clinical trials on Chlamydia Infections. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using Radiant Insigths, Inc. proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials ...

Childhood Epilepsy Global Clinical Trials Review, H1, 2017

Childhood Epilepsy Global Clinical Trials Review, H1, 2017 Summary Radiant Insigths, Inc. clinical trial report, " Childhood Epilepsy Global Clinical Trials Review, H1, 2017 " provides an overview of Childhood Epilepsy clinical trials scenario. This report provides top line data relating to the clinical trials on Childhood Epilepsy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using Radiant Insigths, Inc. proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database...

Global Ozone Therapy Sales Industry Demand, Analysis & Forecasts Market 2017

In this report, the global Ozone Therapy market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Ozone Therapy for these regions, from 2012 to 2022 (forecast), covering United States China Europe Japan Southeast Asia India Download full research Report @ http://www.radiantinsights.com/research/global-ozone-therapy-sales-market-report-2017 Global Ozone Therapy market competition by top manufacturers/players, with Ozone Therapy sales volume, Price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including Kastner-Praxisbedarf GmbH Herrmann Apparatebau GmbH Humares GmbH Zotzmann + Stahl GmbH + Co. KG Dr.J.Hansler GmbH Ozonline Sedecal Apoza Fumeier Weimei Group Shenzhen Koye Medical ...

Wealth in Russia Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2017

The performance of the Russian liquid wealth market is driven by strong growth in the retail savings and investments market. Given the predominant allocation in deposits, year-on-year growth has depended primarily on GDP and wage growth, which in turn have been influenced by commodity prices. While HNW wealth is forecast to record a compound annual growth rate (CAGR) of 12.3% between 2016 and 2020, the rest of the country's affluent population is expected to develop at a slower pace. Key Findings - At the end of 2015, 1.79 million Russian adults could be considered affluent, representing just 1.6% of the adult population but accounting for 97% of total retail liquid assets. The total liquid wealth of affluent individuals amounted to $428bn, with HNW individuals holding $163bn (37.9%). - The retail savings and investment market is forecast to grow by 9% in 2016 and 15% in 2017. From 2016 onward the macroeconomic environment is forecast to improve, and there should be a noticea...